Can AI find hidden breast markers? new study aims to find out

NCT ID NCT07427407

Not yet recruiting Diagnosis Sponsor: AURA Health Technologies Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test an AI-enhanced ultrasound system to see if it can detect breast biopsy markers placed during standard care. About 100 adult women scheduled for breast tumor removal will have a short ultrasound scan. The AI software will try to locate the marker, but results won't change the patient's treatment. The goal is to improve future imaging tools.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this AI tool could help doctors more easily find biopsy markers during breast cancer surgery, potentially improving precision.
What could go wrong: This is an early observational study with only 100 participants. The AI may not work well in all cases, and it is not yet used for diagnosis or treatment decisions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Show contact details

Locations

Columbia University Irving Medical Center

New York, New York, 10032, United States

Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.